Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity
Joonhee Park, Jay Daniels, Tim Wartewig, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1225-1236
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 69
Naturally occurring T cell mutations enhance engineered T cell therapies
Julie Garcia, Jay Daniels, Yujin Lee, et al.
Nature (2024) Vol. 626, Iss. 7999, pp. 626-634
Closed Access | Times Cited: 36
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Calvin Law, Vanessa Sue Wacleche, Ye Cao, et al.
Nature (2024) Vol. 631, Iss. 8022, pp. 857-866
Closed Access | Times Cited: 23
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 51
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Álvaro Andrades, Paola Peinado, Juan Carlos Álvarez-Pérez, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Engineering strategies to safely drive CAR T-cells into the future
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma
Katharina Rindler, Constanze Jonak, Natalia Alkon, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma
Yuxin Du, Yun Cai, Yan Lv, et al.
Cancer Letters (2022) Vol. 551, pp. 215972-215972
Open Access | Times Cited: 38
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma
Tim Wartewig, Jay Daniels, Miriam Schulz, et al.
Nature Cancer (2023) Vol. 4, Iss. 10, pp. 1508-1525
Open Access | Times Cited: 22
Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment
Yumei Gao, Simeng Hu, Ruoyan Li, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 18
The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy
Mohamed Abou‐El‐Enein
Blood Cancer Discovery (2024) Vol. 5, Iss. 4, pp. 249-257
Closed Access | Times Cited: 8
Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1313-1328
Open Access | Times Cited: 38
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma
Xiaofei Song, Shiun Chang, Lucia Seminario‐Vidal, et al.
Cancer Discovery (2022) Vol. 12, Iss. 5, pp. 1294-1313
Open Access | Times Cited: 27
Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2020) Vol. 95, Iss. 10, pp. 1209-1213
Open Access | Times Cited: 39
Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Alexandra E. Khaleel, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 12, pp. 2610-2622
Open Access | Times Cited: 21
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
Amrita Goyal, Daniel E. O’Leary, Francine M. Foss
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 41-51
Closed Access | Times Cited: 12
Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues
Roberto N. Miranda, Catalina Amador, John K.C. Chan, et al.
Modern Pathology (2024) Vol. 37, Iss. 8, pp. 100512-100512
Closed Access | Times Cited: 4
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
New Facets of Hematolymphoid Eponymic Diseases
C.S. Ng, Jilong Qin
Lymphatics (2025) Vol. 3, Iss. 2, pp. 9-9
Open Access
A novel knockout mouse model to assess the impact of one-copy loss of Hnrnpk in CD4 + T cells in chronically inflamed skin as a prelude to CTCL
Yixin Luo, Maarten H. Vermeer, Margot M. Linssen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Overexpression of FOXM1 drives mycosis fungoides progression by regulating the cell cycle
Kecen Liu, Huizhong Wang, Jingyang Dang, et al.
Journal of Dermatological Science (2025)
Closed Access
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
Caroline S. Myers, Eli S. Williams, Carlos Barrionuevo Cornejo, et al.
Haematologica (2024)
Open Access | Times Cited: 3
Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Relapsed/Refractory IIB/IVB Mycosis Fungoides / Sézary Syndrome Patients after Previous Systemic Treatment. EORTC-1652-CLTG “PARCT”
Rudolf Stadler, Gabriele Roccuzzo, Pablo L. Ortiz‐Romero, et al.
European Journal of Cancer (2025) Vol. 222, pp. 115484-115484
Open Access
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies
Shigeki Yagyu, Yozo Nakazawa
International Journal of Clinical Oncology (2023) Vol. 28, Iss. 6, pp. 736-747
Closed Access | Times Cited: 9
Next-generation sequencing in dermatology
Andrew King, Hany Deirawan, Paytra A. Klein, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top